Biosciences Equities

Ventyx Biosciences Begins Phase 2a Trial for Parkinson's Treatment VTX3232 Sep 7, 2024

Ventyx Biosciences Shareholders May Have a Claim in Class Action Lawsuit Mar 24, 2024

Pressure BioSciences Announces Major Order for UltraShear Technology Platform from New Client Jan 19, 2024